The prefilled syringe is approved as a 20-to-30-second subcutaneous injection, where patients are able to self-inject following proper instruction in subcutaneous injection technique.:
Source: Neurology Read More
FDA Approves Pre-Filled Syringe Administration for FcRn Modulator Efgartigimod
Related Posts
<![CDATA[FDA AdComm Votes Against Recommending
Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in
AD, Salanersen’s FDA Breakthrough Designation
Meaning]]>
<![CDATA[FDA AdComm Votes Against Recommending Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in AD, Salanersen’s FDA Breakthrough Designation Meaning]]>
